Jasper Therapeutics, Inc. (JSPR) Reports In-Line Q1 EPS

Jasper Therapeutics, Inc. (NASDAQ: JSPR) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16).

For earnings history and earnings-related data on Jasper Therapeutics, Inc. (JSPR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c